membranes which arise after rhegmatogenous retinal detachment, PDR membranes (including those which fol low diabetic vitrectomy such as in retrosilicone oil neo vascularisation 3. 4 and some cases of reparative epiretinal fibrosis') have a prominent vascular component."
The blood vessels which extend into the vitreoretinal interface during the formation of PDR membranes are accompanied by a variety of cell types including fibro blasts of unknown origin, inflammatory cells, retinal glia and, possibly, retinal pigment epithelial cells.&-u These cells are responsible for several features of PDR mem branes such as scar-like contractionl4 and collagen accum ulation in the extracellular matrix (ECM).
The Extracellular Matrix of PDR Membranes
The collagen of PDR membranes has been investigated by immunofluorescence and SDS polyacrylamide gel electrophoresis and has been shown to contain types I to v.12 . 1 , The accretion of collagen in the tissue led to the con cept that the cell-mediated contraction within the tissue was consolidated and stabilised by the ECM.2 However, the ECM of the membranes has been shown to contain other components such as the ECM glycoproteins.1 2 .15 ECM glycoproteins have multiple biological functions encompassing roles in early ECM assembly and in cell substratum adhesion.16-lx Cell-ECM adhesion is mediated by cell surface receptors including those of the integrin family and it is thought that ECM glycoprotein-integrin interactions profoundly influence cell activities such as cellular proliferation, migration and differentiation. 1 9 -2 1 In view of the effects of ECM glycoproteins on cell behav iour, it is likely that the ECM of PDR membranes not only stabilises membrane contraction but also modulates mem brane development. Consequently, much interest has been generated in PDR membrane glycoproteins. One of the first ECM glycoproteins to be discovered in PDR membranes wasfibronectin. 1 2 Fibronectin is abun-dant in the tissue but its origin in PDR membranes is unclear. There is some evidence that a soluble type of fibronectin (plasma fibronectin) enters the vitreal cavity following breakdown of the blood-retina barrier 2 2.23 and could thus become incorporated in developing PDR mem branes. However, a form of insoluble fibronectin produced by cells (cellular fibronectin) is also found in PDR mem branes24-26 and recently we have presented evidence that glial, fibroblastic and retinal pigment epithelial cells can produce fibronectin within some intravitreal mem branes.27 For example, intravitreal membranes which complicate rhegmatogenous retinal detachment contain cells replete with fibronectin messenger RNA (mRNA) while cells in the underlying retina express little fibronec tin mRNA. 27 To investigate further the origins of fibronectin in PDR membranes we are employing an in situ hybridisation technique to evaluate fibronectin mRNA in cells in mem brane specimens and the underlying retina. 27 The findings are compared with fibronectin immunoreactivity in the specimens. Here we present our preliminary results based on PDR membranes and retina in enucleated eyes.
MATERIAL S AND METHOD S

Contr ol Tissue
Proliferative tissue from rheumatoid arthritis synovium known to contain abundant human cellular fibronectin mRNA and to show strong fibronectin immunoreactivity 2 8 was used as the positive control tissue for the hybrid isation experiments and immunohistochemical pro cedures.
Gl obes Containing PDR Membranes
Four globes known to contain PDR membranes (Table I) were used in this initial study. The globes were obtained from the files of the Pathology Department at the Institute of Ophthalmology.
Preparation of Single Stranded RNA Pr obes
Single stranded RNA probes (riboprobes) were prepared as previously reported.27.28 A cDNA clone (pFHl), equiva lent to about one quarter of the estimated size of human cellular fibronectin mRNA,2 9 .30 was provided by Dr. F. E. Baralle, Sir William Dunn School of Pathology, Univer sity of Oxford. The plasmid was double digested, purified and inserted into the SP6(T7 vector Riboprobe Gemini pGEM-blue (pGEM, Promega, Wisconsin, USA).
Radiolabelled anti-sense and sense (control) riboprobes were produced from linearised plasmid template by incor porating 35S-labelled CTP (specific activity approx. 800 Ci/mmol; Amersham International, Bucks., UK) with the standard transcription reaction, employing SP6 or T7 RNA polymerase (Boehringer Mannheim, FRG).
Optimal probe length for tissue penetration was achieved using alkaline hydrolysis and checked by gel electrophoresis and autoradiographic blotting.3l Radio labelled probes were stored at -20°C until used.
Hybridisati on Hist ochemistry
The globes were fixed for between 4 and 48 hours in 10% formol-saline, dehydrated in graded concentrations of eth anol and embedded in paraffin wax. Sections (6 /-lm tJ;1ick) of wax-embedded tissue were placed on 2% 3-amino propyltriethoxysilane-coated glass slides (Sigma, Poole, Dorset, UK), dew axed and permeabilised. The specimens were treated with Proteinase K, post-fixed, dehydrated and air-dried. The anti-sense (SP6, fibronectin mRNA) probe was then applied at a concentration of 0.2 ng//-ll in hybridisation medium. The sections were covered with coverslips overnight at 37°C in a humid chamber. To pre vent RNAse contamination, RNAse-free conditions were implemented in all methods up to and including hybrid isation. Following removal of the covers lips and unbound probe as previously described,27 the specimens were dehy drated in ascending concentrations of ethanol containing 0.3 M ammonium acetate and air-dried.
Sites of probe binding were detected autoradiograph ically. The slides were coated with K5 nuclear emulsion (liford, Cheshire, UK), dried and kept at 4°C in the dark. They were then developed with D-19 developer (Kodak, Herts., UK) fixed with Hypam fix, counterstained with Mayer's haematoxylin and mounted.
Contr ol Pr ocedures
Controls were run to check the specificity of the probe binding: (1) sections were treated with 20 /-lg/ml RNAse to remove all tissue RNA before hybridisation with the anti sense probe; (2) other sections were incubated with the sense (T7) probe at a concentration of 0.2 ng//-ll instead of the fibronectin (anti-sense) probe.
Immunohist ochemistry
Serial sections 6 /-lm thick of the wax-embedded tissue 'Isolated macrophage-like cells in underlying retina also contained fibronectin mRNA.
blocks used for in situ hybridisation were immunostained for fibronectin, glial fibrillary acidic protein (GFAP; to detect glial cells) or cytokeratins (to identify retinal pig ment epithelial cells) as previously described. 3 2-3 4 The immunoperoxidase technique was employed with the per oxidase substrate 3-amino-9-ethylcarbazole (AEC), which yielded a pink/red reaction product. Some sections were counterstained with Mayer's haematoxylin. Controls were applied to all immunostaining procedures as pre viously described. 3 2-3 4 Sections employed in the autoradiographic and immunohistochemical studies were examined and com pared by bright field and differential interference contrast microscopy. Semi-quantitative assessments of hybridisa tion or immunohistochemical labelling were made as pre viously described.27 Thus labelling at the level of the negative controls was designated 'background labelling', labelling equivalent to the most intense seen in positive controls was called 'intense labelling' and labelling inter- 
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mediate between intense and background was termed 'moderate labelling'.
RESULTS
Retina
In three of the four globes, occasional isolated round cells exhibiting moderate or intense anti-sense probe binding were observed in the retina (Fig. 1) . These cells often showed a macrophage-like morphology and frequently contained pigment. In addition, moderate labelling for fibronectin mRNA was seen in cells in the walls of some retinal vessels. The remaining retinal cells exhibited back ground levels of signal for fibronectin mRNA.
Moderate or intense fibronectin immunoreactivity was observed in the lumina and walls of retinal vessels. Foci of extravascular fibronectin also were seen around some vessels and occasionally patchy fibronectin staining was seen in the inner or outer retina (Fig. 2) . The extravascular fibronectin staining pattern was similar to that of albumin in retina following breakdown of the blood-retina bar rier35 and did not appear to be related to the distribution of the isolated fibronectin mRNA-containing cells.
lntravitreal Membranes
PDR membranes in two of the four globes contained cells which labelled with the anti-sense probe ( Fig. 1; Table I ); in one specimen 60% of the cells showed levels of labell ing above background and a third of these cells exhibited intense labelling. The remaining fibronectin mRNA-con taining membrane cells showed moderate probe binding (Table I) . Patchy, moderate to intense fibronectin immuno reactivity was observed in all the PDR membranes, including those which did not contain cells that bound the anti-sense probe (Fig. 2) .
The PDR membrane cells which contained fibronectin mRNA were isolated in the specimens, and aggregated cells were not observed in the membranes. It was not poss ible to trace individual cells through sequential autoradio graphic and immunohistochemical sections with any degree of accuracy and, therefore, we could not determine the origins of the cells which labelled with the fibronectin. However, fibronectin mRNA was observed in both spindle-shaped fibroblast-like cells and rounded macro phage-like cells in the membranes (Fig. 1) . Endothelial cells in some membrane vessels also showed moderate labelling with the anti-sense probe.
DISCUSSION
We were surprised to find intraretinal macrophage-like cells which contained fibronectin mRNA in the eyes since, in a previous study,27 we did not see comparable cells in detached retina in globes from non-diabetic patients. The reason for the difference between the two studies is obscure. However, intraretinal phagocytic cells may be seen in PDR36 and macrophages are known to produce fibronectin (which can act as an opsinising agent). 37 Our results show that fibronectin immunostaining is present in PDR membranes devoid of cells containing detectable fibronectin mRNA. The lack of fibronectin producing cells in some fibronectin-containing mem branes could reflect deposition of insoluble cellular fibro nectin by cells which have subsequently degenerated or migrated out of long-standing tissue. However, develop ing PDR membranes may incorporate fibronectin from the vitreous since the vitreous in PDR contains a soluble form of the glycoprotein.23 Vitreous fibronectin is presumed to be derived from the plasma following breakdown of the blood-retina barrier,22 and the pattern of intraretinal fibro nectin immunoreactivity in our specimens concurs with this concept. 35 Thus our findings support the idea that some of the fibronectin in the developing tissue originates from plasma-derived, vitreous fibronectin.
Conversely, cells in some well-established PDR mem branes are replete with fibronectin message, indicating that fibronectin within PDR membranes partly originates from the membrane cells themselves. Indeed, recent immunohistochemical investigations demonstrate that PDR membranes may contain insoluble cellular fibronec tin?4-26 Consequently, it seems likely that the fibronectin in PDR membranes originates from both the membrane cells and plasma-derived fibronectin.
The agglomeration of both cellular and plasma fibro nectin in PDR membranes is comparable to that seen in reparative tissues elsewhere in the body.37 For example, plasma and locally produced fibronectin collect in healing myocardial infarcts,38 and recently we have found evi dence that the fibronectin in epiretinal and subretinal membranes of proliferative vitreoretinopathy is also derived from the plasma and membrane cells. 27, 39 Fibronectin-producing cells in periretinal membranes of proliferative vitreoretinopathy included retinal pigment epithelial" glial, fibroblastic and macrophage-like cells.27.39 Fibroblast-like and macrophage-like cells with abundant fibronectin mRNA were present in PDR mem branes and some of these cells may have been glial or, possibly, retinal pigment epithelial in origin. However, we were unable to distinguish the precise origins of the fibro nectin-producing cells (other than vascular endothelia which sometimes exhibited moderate levels of fibronectin mRNA) in this preliminary study because of the absence of well-defined cell aggregates within the established PDR membranes. We hope to clarify further the origins of fibronectin-producing cells in our continuing investiga tions (employing PDR membrane biopsies obtained at vitrectomy).
The abundance of locally produced and plasma-derived fibronectin, together with previous observations of related ECM glycoproteins and cell surface receptors of the integ rin family,40 in PDR membranes indicate that the ECM has an important role in PDR membrane progression. More over, the present evidence suggests that ECM-integrin interactions represent potential therapeutic targets in pre venting PDR membrane formation.
